BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Special

The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia

This is especially concerning in Asia, where rates of illness are expected to rise in the coming years. When it comes to breast cancer, for instance, Asia ...

September 20, 2024 | Opinion | By Deepti Saraf General Manager, Roche (Malaysia) Sdn. Bhd.

Redefining Patient Safety in the Age of Healthtech

A few weeks ago, I sat down to watch Live to 100: Secrets of the Blue Zones on Netflix. The documentary explores pockets of the world where people ...

September 18, 2024 | Opinion | By Reuben Ong, Vice President of Healthcare, DKSH

Jorge Sahlieh on Adapting Cardinal Health’s Products and Services to Tackle Healthcare's Pressing Financial and Workforce Challenges

In this exclusive interview with BioPharma APAC, Jorge Sahlieh, President of International Medical Products and Distribution at Cardinal Health, sh...

September 12, 2024 | Interview

Australia Faces Urgent Call to Address Childhood Dementia Crisis in New 2024 Report

A groundbreaking new report, "State of Childhood Dementia in Australia 2024," released at Australia's Parliament House in Ca...

September 10, 2024 | Report

Inside Asia-Pacific’s Cell and Gene Therapy Evolution: A Conversation with Raymond Chow, VP of Commercial, APAC at Cytiva

In an interaction with BioPharma APAC, Raymond Chow, Vice President of Commercial for Asia-Pacific at Cytiva, shares his insights on the rapidly evolving l...

September 02, 2024 | Interaction

New Trials, New Pills—The Pharma Rollercoaster Continues!

The Landscape of Innovation: A Double-Edged Sword The pace at which pharmaceutical companies are developing new drugs is nothing short of astonish...

August 30, 2024 | Report

Mabwell Receives NMPA Approval to Initiate Phase III Study of 9MW2821 in Recurrent or Metastatic Cervical Cancer

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (C...

August 26, 2024 | News

Strategic Vision Meets Execution: Glen Godresse's Bold Moves in His First 100 Days as CEO of Menarini Asia-Pacific

In a candid conversation with BioPharma APAC, Glen Godresse, CEO of Menarini Asia-Pacific, reflects on his first 100 days at the helm, highlighting...

August 23, 2024 | Interview

Tackling Dengue: Insights from Leading Experts Amid Surge in Southeast Asia

In an exclusive interview with BioPharma APAC, Professor Ooi Eng Eong, a leading expert in Emerging Infectious Diseases at Duke-NUS Medical School,...

August 22, 2024 | Interview

Driving Healthcare Innovation in Asia: Rehan Saghir of ZP Therapeutics on Pioneering Drug Commercialization and Overcoming Regional Challenges

In an exclusive interview with BioPharma APAC, Rehan Saghir, Executive Vice President of ZP Therapeutics, Zuellig Pharma shares his expert insights...

August 20, 2024 | News

Alexandre de Muralt Discusses Merck's Tailored Strategies in the APAC Region and Commitment to Boosting Fertility Rates, Formed from a Deep Understanding of this Complex Market

In an exclusive interview with BioPharma APAC, Alexandre de Muralt, Senior Vice President of Asia Pacific for Merck’s healthcare business, shares his...

August 20, 2024 | Interview